NCT04212910 Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
| NCT ID | NCT04212910 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Endometrium Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 101 participants |
| Start Date | 2019-07-23 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 101 participants in total. It began in 2019-07-23 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.
Eligibility Criteria
Inclusion Criteria: * histopathological confirmation of a primary endometrial cancer * age \> 18 years * no contraindication to surgery (comorbidity, contraindication or lack of consent) * no contraindication to preoperative imaging * visible tumor at imaging * signed inform consent. Exclusion Criteria: * patients unsuitable for surgical intervention (comorbidity, contraindication or lack of consent, poor performance status) * age \< 18 years, c) inability to complete the needed imaging examination (ie, severe claustrophobia) * any additional medical condition that may significantly interfere with study compliance * all the contraindication for MRI (ie, pacemaker).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04212910 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometrium Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04212910 currently recruiting?
Yes, NCT04212910 is actively recruiting participants. Contact the research team at steidler.stephanie@hsr.it for enrollment information.
Where is the NCT04212910 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT04212910 clinical trial?
NCT04212910 is sponsored by IRCCS San Raffaele. The trial plans to enroll 101 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.